CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Sundry Debtors History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Sundry Debtors | ₹4,771 Cr | ₹4,057 Cr | ₹3,424 Cr | ₹3,446 Cr | ₹3,891 Cr |
What is the latest Sundry Debtors ratio of CIPLA ?
Year | Sundry Debtors |
---|---|
Mar2024 | ₹4,771 Cr |
Mar2023 | ₹4,057 Cr |
Mar2022 | ₹3,424 Cr |
Mar2021 | ₹3,446 Cr |
Mar2020 | ₹3,891 Cr |
How is Sundry Debtors of CIPLA Trending?
Years | Sundry Debtors | % Change | |
---|---|---|---|
Mar2024 | ₹4,771 Cr | 17.59 | |
Mar2023 | ₹4,057 Cr | 18.47 | |
Mar2022 | ₹3,424 Cr | -0.62 | |
Mar2021 | ₹3,446 Cr | -11.45 | |
Mar2020 | ₹3,891 Cr | - |
Compare Sundry Debtors of peers of CIPLA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CIPLA | ₹125,533.3 Cr | 0.9% | 0.1% | 14.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹441,910.0 Cr | 2.5% | 0.2% | 17.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹160,035.0 Cr | 2.1% | 3.7% | 66.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹112,894.0 Cr | -0.6% | 0.4% | 28.3% | Stock Analytics | |
MANKIND PHARMA | ₹105,587.0 Cr | -1.2% | 5.6% | 11.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,110.0 Cr | -0.3% | -2.2% | -0.1% | Stock Analytics |
CIPLA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CIPLA | 0.9% |
0.1% |
14.6% |
SENSEX | 1% |
4.3% |
8.9% |
You may also like the below Video Courses